Filing Details
- Accession Number:
- 0002001011-25-000048
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-24 20:29:59
- Reporting Period:
- 2025-06-23
- Filing Date:
- 2025-06-24
- Accepted Time:
- 2025-06-24 20:29:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 886163 | Ligand Pharmaceuticals Inc | LGND | Pharmaceutical Preparations (2834) | 770160744 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1950232 | Andrew Reardon | 555 Heritage Drive Suite 200 Jupiter FL 33458 | Clo & Secretary | No | Yes | No | No |
Transaction Summary
| Sold: | 500 shares | Avg. Price: $114.08 | Total Value: $57,042.15 |
| Number of Shares After Transactions: | 31,903 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-06-23 | 500 | $114.08 | 31,903 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
